Group 1 - The company held its 21st temporary meeting of the fifth supervisory board on August 8, 2025, to discuss the continuation of its asset pool business [1][2] - The supervisory board believes that continuing the asset pool business will enhance the efficiency and returns of the company's assets, benefiting long-term development without harming the interests of the company and minority shareholders [1][2] - The company plans to engage in asset pool business with a total amount not exceeding 100 million RMB and provide guarantees, in compliance with relevant regulations [2] Group 2 - The voting results for the proposal were 3 votes in favor, 0 against, and 0 abstentions, indicating unanimous support from the supervisory board [2] - The proposal will be submitted for approval at the shareholders' meeting [2]

Group 1 - The company, Reap Bio (300119), announced that it will hold its fourth extraordinary general meeting of shareholders on August 25, 2025 [1] - The agenda for the meeting includes the proposal for the company and its subsidiaries to continue engaging in asset pool business and providing guarantees [1]

一、担保情况概述 1、基本情况 证券代码：300119 证券简称：瑞普生物 公告编号：2025-060 瑞普生物股份有限公司 关于公司及子公司继续开展资产池业务并提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 2024 年 3 月 8 日，公司第五届董事会第十二次（临时）会议及第五届监事 会第九次（临时）会议审议通过了《关于公司及子公司继续开展资产池业务并提 供担保的议案》，公司及部分分子公司与浙商银行股份有限公司天津分行（以下 简称"浙商银行天津分行"）开展总额不超过 1 亿元的资产池业务，有效期一年。 详见公司在 深 圳 证 券 交 易 所 网 站 （ http://www.szse.cn ） 及 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露的《关于公司及子公司继续开展资产池业务并 提供担保的公告》（公告编号：2024-010）。 为保障公司业务的连续性，盘活资产，提高流动资产的使用效率，公司及部 分分子公司，即：瑞普（天津）生物药业有限公司（以下简称"瑞普天津"）、 瑞普（保定）生物药业有限公司（以下简称" ...

证券代码：300119 证券简称：瑞普生物 公告编号：2025-061 关于召开 2025 年第四次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本次股东大会召开的基本情况 1、股东大会届次：2025年第四次临时股东大会 2、会议召集人：经公司第五届董事会第二十五次（临时）会议审议通过， 公司董事会决定召开2025年第四次临时股东大会。 3、会议召开的合法、合规性：本次股东大会的召集程序符合有关法律、行 政法规、部门规章、规范性文件和《公司章程》的规定。 4、会议召开时间： 现场会议召开时间：2025 年 8 月 25 日（星期一）14:30 瑞普生物股份有限公司 网络投票时间为： 通过深圳证券交易所交易系统进行网络投票的时间为2025年8月25日09:15- 09:25、09:30-11:30和13:00-15:00； 通过深圳证券交易所互联网系统投票的具体时间为2025年8月25日09:15- 15:00期间的任意时间。 5、会议的召开方式：本次股东大会采取现场投票与网络投票相结合的方 式。 （1）现场投票：包括本人出席及通过填写 ...

第五届监事会第二十一次（临时）会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、监事会会议召开情况 瑞普生物股份有限公司（以下简称"公司"）第五届监事会第二十一次（临 时）会议于 2025 年 8 月 8 日在公司会议室以现场方式召开。会议通知于 2025 年 8 月 5 日以书面及网络方式送达全体监事。公司应出席监事 3 人，实际出席监事 3 人，参与表决监事 3 人。本次会议由周仲华先生主持。本次会议的召集、召开 和表决程序符合《公司法》《证券法》等法律法规和《公司章程》的规定。 二、监事会会议审议情况 1、审议通过了《关于公司及子公司继续开展资产池业务并提供担保的议案》 证券代码：300119 证券简称：瑞普生物 公告编号：2025-059 瑞普生物股份有限公司 具体内容详见公司于 2025 年 8 月 8 日披露于深圳证券交易所网站 （http://www.szse.cn）及巨潮资讯网（http://www.cninfo.com.cn）的《关于公司及 子公司继续开展资产池业务并提供担保的公告》。 表决结果：同意 3 票，反对 0 票，弃 ...

瑞普生物股份有限公司 第五届董事会第二十五次（临时）会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、董事会会议召开情况 瑞普生物股份有限公司（以下简称"公司"）第五届董事会第二十五次（临 时）会议于 2025 年 8 月 8 日在公司会议室以现场结合通讯表决方式召开。会议 通知于 2025 年 8 月 5 日以书面及网络方式送达全体董事。公司应出席董事 9 人， 实际出席董事 9 人，参与表决董事 9 人（其中董事李睿、杨鶄，独立董事郭春林、 才学鹏、李娅以通讯方式参会）。本次会议由董事长李守军先生主持，公司高级 管理人员列席了会议。本次会议的召集、召开和表决程序符合《公司法》《证券 法》等法律法规和《公司章程》的规定。 证券代码：300119 证券简称：瑞普生物 公告编号：2025-058 公司参与资产池业务主体有：分公司、全资子公司及控股子公司，具有较为 充足的偿还债务能力，公司能够对其实施有效的业务、资金管理和风险控制，对 其提供担保不会影响公司主营业务的正常开展。控股子公司龙翔药业提供反担保， 此次资产池业务的财务风险处于公司可控的范 ...

Investment Rating - The report maintains a "Recommended" rating for the agricultural, forestry, animal husbandry, and fishery industry [1][8]. Core Viewpoints - The report highlights a long-term revaluation opportunity for the pig industry, indicating that while pig prices are experiencing fluctuations, there is still downward pressure. The industry is expected to transition towards a self-regulatory and stable phase, benefiting leading companies such as Wens Foodstuffs, Muyuan Foods, and Juxing Agriculture [4][14]. - The poultry sector is currently facing low prices, but there are signs of marginal improvement in the cycle, with recommendations for companies like Shennong Development and Lihua Stock [5][24]. - The animal health sector is anticipated to see performance recovery and investment opportunities in pet medical services, with a focus on companies like Kexin Biological and Ruipuhua [6][34]. - The planting sector is experiencing a decline in the pig-to-grain price ratio, with ongoing commercialization of genetically modified seeds benefiting early adopters [7][37]. - The feed sector is witnessing price fluctuations, with recommendations for Haida Group and attention to He Feng Stock [7][42]. - The pet economy is thriving, with domestic brands gaining strength, and the report recommends companies in the pet food sector such as Guibao Pet and Zhongchong Stock [7][51]. Summary by Sections Pig Industry - The average price of pigs is currently around 14.08 yuan/kg, with fluctuations noted [14]. - The number of breeding sows has increased slightly, indicating a stable supply [14]. - Key recommendations include Wens Foodstuffs, Muyuan Foods, and Juxing Agriculture, with a suggestion to pay attention to Dekang Agriculture [4][14]. Poultry Industry - The price of white feather chicken is low, with a focus on potential marginal improvements in the cycle [5][23]. - The report notes a significant update in the breeding stock, with a mix of imported and self-bred varieties [5][24]. - Recommended companies include Shennong Development and Lihua Stock [5][24]. Animal Health - The report anticipates continued recovery in animal health companies' performance, supported by stable profits in the pig farming sector [6][34]. - The approval of mRNA vaccines for veterinary use marks a significant technological advancement [6][34]. - Recommended companies include Kexin Biological and Ruipuhua, with additional attention to Huisheng Biological and Jinhai Biological [6][34]. Planting Sector - The pig-to-grain price ratio has decreased, with ongoing commercialization of genetically modified seeds [7][37]. - Recommendations include Suqian Agricultural Development and Longping High-Tech [7][37]. Feed Sector - Feed prices are experiencing fluctuations, with specific prices noted for different types of feed [7][42]. - The report suggests that the feed industry is likely to see increased concentration, recommending Haida Group and monitoring He Feng Stock [7][42]. Pet Industry - The pet market is growing, with a significant increase in consumption and brand development [7][51]. - Recommendations include Guibao Pet, Zhongchong Stock, and Peidi Stock in the pet food sector, as well as Ruipuhua in the pet medical sector [7][51].

Investment Rating - The report maintains an "Overweight" rating for the agriculture, forestry, animal husbandry, and fishery industry [1][42]. Core Insights - The SW agriculture, forestry, animal husbandry, and fishery industry slightly outperformed the CSI 300 index, with an increase of 1.06% from July 18 to July 31, 2025, surpassing the index by approximately 0.05 percentage points [3][10]. - Most sub-sectors recorded positive returns during the same period, with fisheries, aquaculture, planting, and feed sectors rising by 2.04%, 1.79%, 1.6%, and 0.64% respectively, while agricultural products processing and animal health sectors saw declines of 0.74% and 3.21% [11][12]. - Approximately 57% of stocks in the industry achieved positive returns, indicating a favorable market sentiment [12]. Industry Data Summary - **Pig Farming**: - The average price of external three-breed pigs decreased from 14.37 CNY/kg to 14.21 CNY/kg between July 18 and July 31, 2025 [21]. - The cost of corn was reported at 2402.02 CNY/ton, showing a slight decline, while soybean meal prices increased to 2984 CNY/ton [22]. - Profitability for self-bred pigs was 43.85 CNY/head, while purchasing piglets resulted in a loss of 116.78 CNY/head [26]. - **Poultry Farming**: - The average price of broiler chicks rose to 2.57 CNY/chick, while egg-laying chicks averaged 3.85 CNY/chick [28]. - The average price for broiler chickens increased to 6.83 CNY/kg, with a slight improvement in profitability to -0.43 CNY/chick [31]. - **Aquaculture**: - The average wholesale price for crucian carp was 22.69 CNY/kg, while carp saw a slight increase to 15.82 CNY/kg [33]. Industry News - The Ministry of Agriculture and Rural Affairs and nine other departments released a plan to promote agricultural product consumption, focusing on optimizing supply, innovating distribution, and activating market demand [35]. - Among the companies reporting mid-year results, Haida Group achieved a revenue of 588.31 billion CNY, a year-on-year increase of 12.5%, with a net profit of 26.39 billion CNY, up 24.16% [36]. Company Insights - Key companies to watch include: - Muyuan Foods (002714): A leading pig farming company with cost and scale advantages [43]. - Haida Group (002311): A top feed company expected to maintain steady market share growth [43]. - Lihua Co. (300761): A leading yellow feather chicken farming company with integrated advantages [43]. - Reap Bio (300119): A leader in the animal health sector with a growing product matrix for pet health [43]. - Zhongchong Co. (002891): A leading pet food company with strong domestic growth prospects [43].

证券日报网讯瑞普生物（300119）7月31日在互动平台回答投资者提问时表示，截至2025年7月18日，公 司股东总户数约2.9万户。 ...

Group 1 - The core business of the company is the research, production, and sales of veterinary drugs, including veterinary biological products and chemical drugs [1] - The company completed the transfer of 48.4213% equity in Hunan Zhong'an Biological Pharmaceutical Co., Ltd. for a transaction amount of 115 million yuan, and still holds 20% equity after the transfer [1] - On July 30, the company's stock closed at 21.36 yuan, down 0.23% from the previous trading day, with a trading volume of 82,415 hands and a transaction amount of 176 million yuan [1] Group 2 - On July 30, the net outflow of main funds for the company was 10.5372 million yuan [2]